Vistin Pharma ASA (OSL:VISTN)
Norway
· Delayed Price · Currency is NOK 21.60
+0.10 (0.47%)
At close: Mar 6, 2026
Vistin Pharma ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 931 | 922 | 1,051 | 1,033 | 701 | 859 | Upgrade
|
| Market Cap Growth | -11.39% | -12.24% | 1.72% | 47.47% | -18.47% | 11.06% | Upgrade
|
| Enterprise Value | 915 | 942 | 1,053 | 1,034 | 739 | 809 | Upgrade
|
| Last Close Price | 21.00 | 20.80 | 22.55 | 20.61 | 13.97 | 17.14 | Upgrade
|
| PE Ratio | 12.46 | 12.34 | 16.75 | 22.66 | - | 34.56 | Upgrade
|
| Forward PE | - | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | Upgrade
|
| PS Ratio | 2.06 | 2.04 | 2.45 | 2.36 | 2.30 | 3.08 | Upgrade
|
| PB Ratio | 2.83 | 2.81 | 3.40 | 3.20 | 2.56 | 3.12 | Upgrade
|
| P/TBV Ratio | 2.83 | 2.81 | 3.40 | 3.20 | 2.56 | 3.12 | Upgrade
|
| P/FCF Ratio | 15.01 | 14.87 | 15.67 | 14.21 | - | - | Upgrade
|
| P/OCF Ratio | 11.83 | 11.72 | 9.74 | 11.41 | - | 62.82 | Upgrade
|
| PEG Ratio | - | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | Upgrade
|
| EV/Sales Ratio | 2.02 | 2.08 | 2.45 | 2.36 | 2.43 | 2.90 | Upgrade
|
| EV/EBITDA Ratio | 7.97 | 8.20 | 10.20 | 12.19 | 138.71 | 18.91 | Upgrade
|
| EV/EBIT Ratio | 9.91 | 10.20 | 12.35 | 15.08 | - | 24.34 | Upgrade
|
| EV/FCF Ratio | 14.76 | 15.18 | 15.71 | 14.23 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | - | 0.18 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | - | 7.95 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.02 | 0.02 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.04 | -0.04 | -0.08 | 0.18 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.13 | -0.13 | -0.11 | -0.31 | 8.95 | -0.80 | Upgrade
|
| Net Debt / FCF Ratio | -0.24 | -0.24 | -0.17 | -0.36 | -0.64 | 1.88 | Upgrade
|
| Asset Turnover | 1.10 | 1.10 | 1.09 | 1.08 | 0.82 | 0.85 | Upgrade
|
| Inventory Turnover | 1.91 | 1.91 | 1.91 | 2.16 | 2.19 | 2.57 | Upgrade
|
| Quick Ratio | 1.54 | 1.54 | 1.01 | 1.24 | 0.62 | 1.92 | Upgrade
|
| Current Ratio | 2.58 | 2.58 | 2.24 | 2.43 | 1.35 | 3.36 | Upgrade
|
| Return on Equity (ROE) | 23.42% | 23.42% | 19.85% | 15.29% | -1.72% | 9.07% | Upgrade
|
| Return on Assets (ROA) | 14.00% | 14.00% | 13.53% | 10.58% | -1.03% | 6.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 22.30% | 23.54% | 22.33% | 17.30% | -2.17% | 11.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 25.60% | 25.60% | 26.60% | 20.50% | -2.10% | 11.40% | Upgrade
|
| Earnings Yield | 8.03% | 8.11% | 5.97% | 4.41% | -0.67% | 2.89% | Upgrade
|
| FCF Yield | 6.66% | 6.73% | 6.38% | 7.03% | -10.68% | -2.13% | Upgrade
|
| Dividend Yield | 6.94% | 7.21% | 5.54% | 4.85% | 5.37% | 4.38% | Upgrade
|
| Payout Ratio | 74.15% | 74.15% | 123.65% | - | - | 89.17% | Upgrade
|
| Total Shareholder Return | 6.94% | 7.21% | 5.54% | 4.85% | 5.37% | 4.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.